medline.ch Respirationstrakt SARS

	Integrating psychosocial health into disaster risk management: Insights from COVID-19 in DurÃ¡n, Ecuador. PLoS One Borbor-Cordova MJ, Searles M, Roa-López H, Cornejo-Rodriguez MDP, Castillo K, Orellana-Manzano A, Campagna CD. PMID: 41894456 [PubMed - indexed for MEDLINE]
	Experiences of registered nurses and nursing assistants during COVID-19: Work stress, stress appraisal, and workplace resources; A qualitative descriptive study. PLoS One Adynski GI, Dictus C, Adynski H, Killela MK, Myer EA, Morgan L, Hmiel H, Williams J. PMID: 41894452 [PubMed - indexed for MEDLINE]
	COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics. PLOS Glob Public Health Ugwu CA, Odebode O, Ajayi IO, Olubunmi J, Ifeoluwa B, Adole JA, Akano K, Okolie J, Eromon P, Kio IK, Amadi J, Adebayo PF, Mgbeokwere I, Lawal AO, Adegoke OA, Adeyemi AO, Owhin S, Ayodeji OO, Ahmed A, Henshaw E, Eyitayo ON, Sylvester AA, Omidele A, Emilola K, Funmilayo O, Oyewale Rufus A, Olakunle OO, Oluwaseun O, Matta AM, Bedekar P, Dahmash L, Forconi CS, Moormann AM, Dinglasan RR, Happi CT, Binder RA. PMID: 41894443 [PubMed]
	Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoires. PLoS One Braun J, Hill ED, Contreras E, Yasuda M, Morgan A, Ditelberg S, Winter E, Callahan C, Mazzoni G, Kirmaier A, Lee GR, Mirebrahim H, Asgharian H, Telman D, Collier AY, Barouch DH, Riedel S, Dutta S, Rubelt F, Arnaout R. PMID: 41894441 [PubMed - indexed for MEDLINE]
	Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States. J Med Econ Yehoshua A, Di Fusco M, Rudolph AE, Thoburn E, Lopez SMC, Dodd J, Yarnoff B. PMID: 41894410 [PubMed - indexed for MEDLINE]
	SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review. Vaccines (Basel) Kamransarkandi M, Varyushina EA, Gorshkov AN, Stukova MA. PMID: 41893818 [PubMed]
	Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice. Vaccines (Basel) Gushchin VA, Siniavin AE, Pochtovyi AA, Dzharullaeva AS, Shcherbinin DN, Ungur AS, Tukhvatulin AI, Shuliakova IV, Kleymenov DA, Mazunina EP, Bykonia EN, Kozlova SR, Usachev EV, Zorkov ID, Grousova DM, Iliukhina AA, Gintsburg AL, Logunov DY. PMID: 41893817 [PubMed]
	The Feasibility of Developing a Universal SARS-CoV-2 Vaccine. Vaccines (Basel) Asaad M, Mustafa MO, Al-Haneedi Y, Shalaby L, Shams Eldin R, Mohamedahmed Y, Yassine HM, Abdallah AM, Emara MM. PMID: 41893795 [PubMed]
	SARS-CoV-2 Infection and Vaccination, Immune Dysregulation, and Cancer. Vaccines (Basel) Pjanova D, Rafeeque A. PMID: 41893791 [PubMed]
	Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): An Immunopathogenic Model of Dysregulated Vaccine-Triggered Immunity. Vaccines (Basel) Siniscalchi C, Basaglia M, Tufano A, Imbalzano E, Di Micco P. PMID: 41893762 [PubMed]
	From Design to Clinical Use: mRNA Vaccines for Infectious Diseases and Cancer. Vaccines (Basel) Cui Y, Liang Z, Cong H. PMID: 41893739 [PubMed]
	Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies. Vaccines (Basel) Hamann SC, Lineburg KE, Ng L, Waugh A, Olver S, Leach J, Bristow C, Raju J, Texier LL, Crooks P, Smith C, Guppy-Coles K, Morris K, Spanevello M, Tey SK, Henden AS. PMID: 41893738 [PubMed]
	SARS-CoV-2 Anti-Spike IgG Subclass Titres in a Population with Prior Exposure to Perfluorooctanoic Acid (PFOA). Toxics Zamfir M, Gerstner D, Lahne H, Fingerle V, Redwitz J, Schober W, Aschenbrenner B, Graw M, Nowak D, Quartucci C, Herr C, Heinze S. PMID: 41893460 [PubMed]
	Successful Treatment of Persistent and Relapsing COVID-19 with Ensitrelvir in a Patient with Obinutuzumab-Induced Long-Term B-Cell Depletion: A Case Report. Reports (MDPI) Haino Y, Kenzaka T, Hayashi T, Yakushijin K. PMID: 41893449 [PubMed]
	Untargeted Sweat and Sebum Volatilomics by HS-SPME-GC/ToF-MS for the Identification of SARS-CoV-2-Associated Biomarkers. Metabolites Longo E, Boselli E, Baldassarre G, Sozio E, Zuccarelli L, Tascini C, Grassi B, Cesco S. PMID: 41893309 [PubMed]
	Fluoxetine Reshapes Macrophage Membrane Sphingolipids and Inflammatory Response Without Affecting Extracellular Vesicle Biogenesis upon Inactivated SARS-CoV-2 Stimulation. Membranes (Basel) de Carvalho JCS, Nobre-Azevedo P, da Silva-Neto PV, Oliveira BTM, Tavares LA, Toro DM, Borges AO, Nascimento MA, Arruda E, Martins RB, Almeida F, Sorgi CA. PMID: 41893283 [PubMed]
	Clinical Evolution of a Cohort of Patients with COVID-19 Treated with Usual Medical Care Plus Polymerized Type I Collagen During the Pandemic Emergency. Med Sci (Basel) Perez-Favila A, Garza-Veloz I, Hernandez-Marquez LS, Martinez-Vazquez MC, Gutierrez-Vela EF, Delgado-Enciso I, Salazar de Santiago A, Luna-Pacheco F, Luna-Pacheco CE, Castañeda-Miranda AG, Martinez-Fierro ML. PMID: 41892833 [PubMed - indexed for MEDLINE]
	Cognitive and Neuropsychiatric Sequelae After SARS-CoV-2 Infection: A Narrative Review and Exploratory Cross-Sectional Study of Neurofilament Light Chain and GFAP. Brain Sci Guzmán Priego CG, Villalpando JMG, Baeza Flores GDC, Ble Castillo JL, Celorio Méndez KDS, Juárez Rojop IE, Martínez López MC, López Villarreal SM, Rodríguez Luis OE, Quiroz Gómez S, Romero Tapia SJ, García Orozco JM, López Nácar WS, Salinas Terrazas OO, Jiménez Aragón KA. PMID: 41892619 [PubMed]
	COVID-19 Infection Risk Among Vulnerable Healthcare Workers: The Protective Role of Pre-Pandemic Recognition. Clin Pract Ladisa M, Cabanilla-Moruno JL, Jiménez-Ortega LE, Delgado-Calderón M, García-Cabrera E, Romero-Barranca J, Vilches-Arenas Á. PMID: 41892492 [PubMed]
	Pre-Exposure Intranasal Treatment with Neomycin Sulfate Reduces Transmission of Influenza B Virus. Antibiotics (Basel) Sergeeva MV, Shamakova D, Kudrya K, Zagriadskii N, Karachevtseva DM, Matichin AA, Muzhikyan A, Stukova M. PMID: 41892407 [PubMed]

Artikel 1 - 20 / 285667

Seite 1 von 14284



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung